Advertisement Advertisement Advertisement Advertisement


February 22, 2017
  • NSAIDs Might Raise AMI Risk During Acute
    Respiratory Infections

    Based on a recent observational study, acetaminophen might be the better recommendation when pharmacists are asked what to take for the aches and pains of colds and the flu. Here’s what the research found about the risk of cardiac events when two potential risk factors—having an acute respiratory infection and taking nonsteroidal anti-inflammatory drugs (NSAIDs)—combine.

  • Vancomycin Lowers Death Rates in Severe
    C Difficile

    Metronidazole might have some advantages in treating Clostridium difficile, but lowering mortality rates in patients with severe infections is not one of them, according to a new study. Researchers point out that those patients are less likely to die when treated with vancomycin. Here are the details.

  • Medicare Patients Tend to Get Older AEDs for Epilepsy, Have Treatment Delays
    A new study found no apparent racial or ethnic bias in how epilepsy patients are treated, but did find that Medicare beneficiaries tend to get older antiepileptic drugs and have treatment delays. How widespread were those issues?
  • Low-Dose 4-in-1 Hypertension Medication Shows Promise

    In a small, preliminary study, a low-dose, 4-in-1 hypertension medication was highly effective in lowering blood pressure with reduced side effects. How successful was the trial and what further research is required?.

Connect With U.S. Pharmacist
USP Google AppUSP Itunes App